These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 26076199)

  • 1. Dynamic Contrast-Enhanced Magnetic Resonance Imaging with Gd-EOB-DTPA for the Evaluation of Liver Fibrosis Induced by Carbon Tetrachloride in Rats.
    Zhang W; Kong X; Wang ZJ; Luo S; Huang W; Zhang LJ
    PLoS One; 2015; 10(6):e0129621. PubMed ID: 26076199
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Gadolinium Ethoxybenzyl Diethylene-triamine-pentaacetic-acid-enhanced Magnetic Resonance Imaging Perfusion and Multiple Hepatobiliary-phase Imaging for Quantitative Assessment of Liver Fibrosis in Rat Models].
    Xu J; Wang X; You Y; Xue HD; Wang Q; Wang ST; Jin ZY
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2018 Dec; 40(6):809-816. PubMed ID: 30606393
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dynamic contrast-enhanced MRI with Gd-EOB-DTPA for the quantitative assessment of early-stage liver fibrosis induced by carbon tetrachloride in rabbits.
    Liu HF; Wang Q; Du YN; Zhu ZH; Li YF; Zou LQ; Xing W
    Magn Reson Imaging; 2020 Jul; 70():57-63. PubMed ID: 32325235
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combining
    Pan S; Wang L; Xin J
    Life Sci; 2021 Mar; 269():119086. PubMed ID: 33476634
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantitative evaluation of liver function with MRI Using Gd-EOB-DTPA.
    Ryeom HK; Kim SH; Kim JY; Kim HJ; Lee JM; Chang YM; Kim YS; Kang DS
    Korean J Radiol; 2004; 5(4):231-9. PubMed ID: 15637473
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The hepatocyte phase of Gd-EOB-DTPA-enhanced MRI in the evaluation of hepatic fibrosis and early liver cirrhosis in a rat model: an experimental study.
    Ma C; Liu A; Wang Y; Geng X; Hao L; Song Q; Sun B; Wang H; Zhao G
    Life Sci; 2014 Jul; 108(2):104-8. PubMed ID: 24881519
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison between T1 relaxation time of Gd-EOB-DTPA-enhanced MRI and liver stiffness measurement of ultrasound elastography in the evaluation of cirrhotic liver.
    Okada M; Murakami T; Yada N; Numata K; Onoda M; Hyodo T; Inoue T; Ishii K; Kudo M
    J Magn Reson Imaging; 2015 Feb; 41(2):329-38. PubMed ID: 24343840
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantitative assessment of hepatic fibrosis in chronic hepatitis B and C: T1 mapping on Gd-EOB-DTPA-enhanced liver magnetic resonance imaging.
    Pan S; Wang XQ; Guo QY
    World J Gastroenterol; 2018 May; 24(18):2024-2035. PubMed ID: 29760545
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New proposal for the staging of nonalcoholic steatohepatitis: evaluation of liver fibrosis on Gd-EOB-DTPA-enhanced MRI.
    Tsuda N; Okada M; Murakami T
    Eur J Radiol; 2010 Jan; 73(1):137-42. PubMed ID: 19026502
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of the efficacy of Gd-EOB-DTPA-enhanced magnetic resonance imaging and magnetic resonance elastography in the detection and staging of hepatic fibrosis.
    Wu WP; Hoi CI; Chen RC; Lin CP; Chou CT
    Medicine (Baltimore); 2017 Oct; 96(42):e8339. PubMed ID: 29049250
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prospective comparison of diffusion-weighted MRI and dynamic Gd-EOB-DTPA-enhanced MRI for detection and staging of hepatic fibrosis in primary sclerosing cholangitis.
    Keller S; Sedlacik J; Schuler T; Buchert R; Avanesov M; Zenouzi R; Lohse AW; Kooijman H; Fiehler J; Schramm C; Yamamura J
    Eur Radiol; 2019 Feb; 29(2):818-828. PubMed ID: 30014204
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Potential of gadolinium-ethoxybenzyl-diethylenetriamine pentaacetic acid (Gd-EOB-DTPA) for differential diagnosis of nonalcoholic steatohepatitis and fatty liver in rats using magnetic resonance imaging.
    Tsuda N; Okada M; Murakami T
    Invest Radiol; 2007 Apr; 42(4):242-7. PubMed ID: 17351431
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessment of liver fibrosis using pharmacokinetic parameters of dynamic contrast-enhanced magnetic resonance imaging.
    Li Z; Sun J; Chen L; Huang N; Hu P; Hu X; Han G; Zhou Y; Bai W; Niu T; Yang X
    J Magn Reson Imaging; 2016 Jul; 44(1):98-104. PubMed ID: 26707910
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessment of liver function in thioacetamide-induced rat acute liver injury using an empirical mathematical model and dynamic contrast-enhanced MRI with Gd-EOB-DTPA.
    Saito S; Moriyama Y; Kobayashi S; Ogihara R; Koto D; Kitamura A; Matsushita T; Nishiura M; Murase K
    J Magn Reson Imaging; 2012 Dec; 36(6):1483-9. PubMed ID: 22711439
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dynamic contrast-enhanced MRI of the liver in Mrp2-deficient rats using the hepatobiliary contrast agent Gd-EOB-DTPA.
    Saito S; Obata A; Kashiwagi Y; Abe K; Murase K
    Invest Radiol; 2013 Jul; 48(7):548-53. PubMed ID: 23442774
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dynamic-contrast-enhanced magnetic resonance imaging of cirrhotic liver parenchyma: A comparison between gadolinium-diethylenetriamine pentaacetic acid and gadolinium-ethoxybenzyl-diethylenetriamine pentaacetic acid.
    Lin CY; Chang WC; Chou CT; Chen RC
    J Chin Med Assoc; 2015 Nov; 78(11):666-72. PubMed ID: 26341453
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Noninvasive Assessment of Liver Fibrosis in Patients with Chronic Hepatitis B or C by Contrast-Enhanced Magnetic Resonance Imaging.
    Hako R; Kristian P; Jarčuška P; Haková I; Hockicková I; Schréter I; Janičko M
    Can J Gastroenterol Hepatol; 2019; 2019():3024630. PubMed ID: 31058108
    [No Abstract]   [Full Text] [Related]  

  • 18. Coefficient of variation on Gd-EOB MR imaging: Correlation with the presence of early-stage hepatocellular carcinoma in patients with chronic hepatitis B.
    Lee JH; Kim YR; Lee GM; Ryu JH; Cho EY; Lee YH; Yoon KH
    Eur J Radiol; 2018 May; 102():95-101. PubMed ID: 29685552
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Experimental hepatic dysfunction: evaluation by MRI with Gd-EOB-DTPA.
    Kim T; Murakami T; Hasuike Y; Gotoh M; Kato N; Takahashi M; Miyazawa T; Narumi Y; Monden M; Nakamura H
    J Magn Reson Imaging; 1997; 7(4):683-8. PubMed ID: 9243389
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessing Liver Function by T1 Maps on Gd-EOB-DTPA-Enhanced MRI for up to 50 Min in Rat Models of Liver Fibrosis: A Longer Hepatobiliary Time Period may Help.
    Xu J; Wang X; Jin ZY; Wang Q; You Y; Wang ST; Qian TY; Xue HD
    Chin Med Sci J; 2021 Jun; 36(2):110-119. PubMed ID: 34231459
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.